Overweight, obesity, and colorectal cancer screening: Disparity between men and women

Department of Psychiatry, Weill Medical College of Cornell University, White Plains, NY, USA. <>
BMC Public Health (Impact Factor: 2.32). 11/2004; 4:53. DOI: 10.1186/1471-2458-4-53
Source: PubMed

ABSTRACT To estimate the association between body-mass index (BMI: kg/m2) and colorectal cancer (CRC) screening among US adults aged >or= 50 years.
Population-based data from the 2001 Behavioral Risk Factor Surveillance Survey. Adults (N = 84,284) aged >or= 50 years were classified by BMI as normal weight (18.5-<25), overweight (25-<30), obesity class I (30-<35), obesity class II (35-<40), and obesity class III (>or= 40). Interval since most recent screening fecal occult blood test (FOBT): (0 = >1 year since last screening vs. 1 = screened within the past year), and screening sigmoidoscopy (SIG): (0 = > 5 years since last screening vs. 1 = within the past 5 years) were the outcomes.
Results differed between men and women. After adjusting for age, health insurance, race, and smoking, we found that, compared to normal weight men, men in the overweight (odds ratio [OR] 1.25, 95% CI = 1.05-1.51) and obesity class I (OR = 1.21, 95% CI = 1.03-1.75) categories were more likely to have obtained a screening SIG within the previous 5 years, while women in the obesity class I (OR = 0.86, 95%CI = 0.78-0.94) and II (OR = 0.88, 95%CI = 0.79-0.99) categories were less likely to have obtained a screening SIG compared to normal weight women. BMI was not associated with FOBT.
Weight may be a correlate of CRC screening behavior but in a different way between men and women.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Obesity is a risk factor for several cancers in postmenopausal women. We attempted to determine cutoffs of adiposity measures in relation to risk of obesity-related cancers among postmenopausal women and to examine the effects of hormone therapy (HT) use on the cutoffs, neither of which has been broadly studied. Methods: We used data from the Women's Health Initiative cohort (n=144,701) and applied Cox-proportional hazards regressions to each combination of 17 cancer types and 6 anthropometric measures (weight, body mass index [BMI], weight to height ratio, waist circumference, waist to hip ratio [WHR], and waist to height ratio). Interactions between the anthropometric measures and HT use were also examined. Cutoffs were determined by applying a grid search followed by a two-fold cross validation method. Survival ROC analysis of 5- and 10-year incidence followed. Results: Breast, colorectal, colon, endometrium, kidney, and all cancers combined were significantly positively associated with all six anthropometric measures, whereas lung cancer among ever smokers was significantly inversely associated with all measures except WHR. The derived cutoffs of each obesity measure varied across cancers (e.g., BMI cutoffs for breast and endometrium cancers were 30 kg/m(2) and 34 kg/m(2), respectively), and also depended on HT use. The Youden indices of the cutoffs for predicting 5- and 10-year cancer incidence were higher among HT never users. Conclusion: Using a panel of different anthropometric measures, we derived optimal cut-offs categorizing populations into high- and low-risk groups, which differed by cancer type and HT use. Although the discrimination abilities of these risk categories were generally poor, the results of this study could serve as a starting point from which to determine adiposity cutoffs for inclusion in risk prediction models for specific cancer types.
    Journal of Women's Health 01/2015; 24(3). DOI:10.1089/jwh.2014.4977 · 1.90 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Difficult colon polyps are not necessarily large, such as those over 2 cm in diameter, but may be relatively small but flat, or may be in a difficult or inaccessible area of the colon. These polyps include lesions that require special maneuvers for their removal. KeywordsSessile adenoma-Flat adenoma-Chromoendoscopy-Non-lifting sign
    04/2011: pages 151-176;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: During the past 2 decades, colorectal cancer (CRC) incidence and mortality rates in the United States have declined in part due to screening. The most recent Behavioral Risk Factor Surveillance System (BRFSS) survey data posted on the CDC website indicate that, in 2008, 52% of adults aged 50 years or older had a fecal occult blood test (FOBT) within the previous year or a lower endoscopy (sigmoidoscopy or colonoscopy) within the previous 5 years [1]. In fact, the majority had either a sigmoidoscopy or colonoscopy (42.3% of respondents), while just 15.3% were screened with a stool test [1]. In 2006, 60.8% of respondents to the same survey reported having had an FOBT within the year preceding the survey or a lower endoscopy within the preceding 10 years, an increase from 56.8% in 2004, 53.9% in 2002, and 53.1% in 2001 [2, 3]. These surveys show that while lower endoscopy screening has increased (43.4% in 2001, 44.8% in 2002, 50.1% in 2004, and 55.7% in 2006), FOBT screening has declined (23.5% in 2001, 21.6% in 2002, 18.5% in 2004, and 16.2% in 2006) [2, 3]. The 2000 National Health Interview Survey (NHIS) found that 49.7% of adults ≥50 years never had CRC testing; only 37.1% were current for their CRC screening [4]. In 2003, the NHIS survey reported higher rates of colonoscopy screening (32.2% in men and 29.8% in women) than FOBT screening (16.1% in men and 15.3% in women) or sigmoidoscopy screening (7.6% in men and 5.9% in women) [5]. In general, self-reported CRC screening rates from all national surveys, which are probably overestimates of actual screening, have increased from less than 25% in the late 1980s to about 60% in 2006, mainly due to increased use of screening colonoscopy [6]. KeywordsFecal occult blood test-Immunochemical-Fecal DNA
    04/2011: pages 123-150;

Preview (2 Sources)

1 Download
Available from